Improved Mobility With Metformin in Myotonic Dystrophy Type 1 Improved Mobility With Metformin in Myotonic Dystrophy Type 1
This Phase II RCT showed promise for metformin for improving the mobility of patients with myotonic dystrophy type 1, the most common form of muscular dystrophy in adults.Brain
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
More News: Brain | Fortamet | Health | Metformin | Muscular Dystrophy | Neurology | Neurosurgery | Reflex Sympathetic Dystrophy